Evaluating the Efficacy and Safety of Treatment With LinearFirm(ULTRAcel Q+) in Temporary Eyebrow Lifting

NCT06457607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2024-06-13

No results posted yet for this study

Summary

Prospective, single center, single arm, open label study to evaluate the efficacy and safety of treatment with LinearFirm(ULTRAcel Q+) in temporary eyebrow lifting

Conditions

  • High Intensity Focused Ultrasound

Interventions

DEVICE

LinearZ

High Intensity Focues Ultrasound

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER
  • Jeisys Medical Inc

    lead INDUSTRY

Principal Investigators

  • Hye Jin Sun · Jeisys Medical Inc

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-24
Primary Completion
2023-09-27
Completion
2023-09-27

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06457607 on ClinicalTrials.gov